Eric Richier is the Head of Microbiology Platform in Global Analytical Sciences for Vaccine CMC Development & Supply at Sanofi, where they lead a team specialized in bacteriology, virology, and molecular biology QC testing. With over 20 years in biologics R&D, Eric has held key roles at institutions such as the Institut de Génétique Moléculaire de Montpellier and Virbac S.A., where they contributed to the development of significant vaccine candidates. Eric completed their PhD in Pharmaceutical and Biological Sciences at the PhD School of Chemical and Biological Sciences for Health and holds a degree in Chemistry from Université Côte d'Azur.
This person is not in any teams
This person is not in any offices